| Title: | Menopausal hormone therapy and incident benign paroxysmal positional vertigo in postmenopausal women: A prospective cohort study using UK Biobank data |
| Journal: | Maturitas |
| Published: | 26 Jul 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42526172/ |
| DOI: | https://doi.org/10.1016/j.maturitas.2026.109076 |
Publication 21333
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
OBJECTIVES: Menopausal hormone therapy and benign paroxysmal positional vertigo, a disorder linked to postmenopausal estrogen deficiency, have not been examined together in a large cohort. We assessed whether hormone therapy is associated with incident positional vertigo and its persistence after cessation.</p>
STUDY DESIGN: We constructed a prospective cohort of 160,617 postmenopausal women from the UK Biobank, excluding prevalent cases, and ascertained hormone therapy status, duration, and time since cessation from self-report. Incident cases were modelled with cause-specific Cox regression on the attained-age scale, adjusting for sociodemographic, lifestyle, cardiometabolic, and comorbidity covariates.</p>
MAIN OUTCOME MEASURES: Incident benign paroxysmal positional vertigo, from the first hospital (ICD-10 H81.1) or primary-care record.</p>
RESULTS: In 157,245 women with complete covariate data (2627 events), the fully adjusted hazard ratio was 1.22 (95% confidence interval 1.09 to 1.38) for current use and 1.28 (1.17 to 1.39) for past use versus never use, stable across adjustment. Risk rose with duration (1.50 at 10 or more years; p for trend <0.001) and persisted after cessation (1.39 at 10 or more years since stopping). The duration-response relationship was stronger for recurrent than single-episode disease (hazard ratio at ten or more years, 1.83 versus 1.41). The association varied with attained age. Exploratory formulation and bone-mineral analyses were inconclusive.</p>
CONCLUSIONS: Menopausal hormone therapy use was positively associated with incident positional vertigo, with a duration-response relationship and persistence after cessation. These pooled estimates are attained-age-averaged and hypothesis-generating; they warrant prospective validation and do not justify changing an individual woman's menopausal hormone therapy regimen.</p>
13 Keywords
- Aged
- Benign Paroxysmal Positional Vertigo
- Biological Specimen Banks
- Estrogen Replacement Therapy
- Female
- Humans
- Incidence
- Middle Aged
- Postmenopause
- Proportional Hazards Models
- Prospective Studies
- UK Biobank
- United Kingdom
8 Authors
- Li Li
- Jingyun Chen
- Xu Han
- Dong Xiao
- Junxin Li
- Xiangyan Cui
- Hong Yu
- Xin Wang
1 Application
| Application ID | Title |
|---|---|
| 996893 | Epidemiological, genetic, immunological and metabolic characterization of otolaryngologic disorders and their systemic disease interactions |
Enabling scientific discoveries that improve human health